CAN-2409 plus valacyclovir significantly improved disease-free survival compared with placebo plus valacyclovir.
Glen Gejerman, MD
Advertisement
Glen Gejerman, MD, is the co-chief of urologic oncology at Hackensack Meridian Health in New Jersey.
Articles by Glen Gejerman, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
2
Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC
3
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
4
BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC
5
